{
  "context": {
    "cell_type": "malignant glioblastoma cell",
    "disease": "glioblastoma",
    "tissue": "brain"
  },
  "input_genes": [
    "LINC02235",
    "AC037486.1",
    "PCDH11X",
    "LINC01829",
    "AL591043.2",
    "ZNF423",
    "ADAMTS18",
    "AL133538.1",
    "DOCK2",
    "SCN1A-AS1",
    "AL022068.1",
    "SEPTIN14",
    "SGCZ",
    "ADAM28",
    "RYR2",
    "DOCK8",
    "ACER2",
    "AC128687.3",
    "AC120193.1",
    "OLR1",
    "AC110296.1",
    "AC109466.1",
    "SPOCK3",
    "ST6GALNAC5",
    "AL136441.1",
    "MLIP",
    "AL158077.2",
    "AP001021.3",
    "CCDC85A",
    "CD96",
    "NRK",
    "C8orf37-AS1",
    "PCDH7",
    "PLD1",
    "CHRNA7",
    "CLRN1",
    "MYO1D",
    "RMST",
    "CNTNAP2",
    "PURPL",
    "RALYL",
    "AL445426.1",
    "RCAN2",
    "AL392023.2",
    "RELN",
    "AL360091.3",
    "AC091946.1",
    "LRRIQ1",
    "CD163",
    "SYN3",
    "IL1RAPL1",
    "LINC01122",
    "LINC01091",
    "AC009126.1",
    "LINC00944",
    "LINC01467",
    "LINC01725",
    "KCNH7",
    "AC069228.1",
    "GNA14-AS1",
    "KCNIP4",
    "LINC00504",
    "AC006299.1",
    "TPRG1",
    "AC003092.1",
    "AC083855.2",
    "FXYD5",
    "SYK",
    "XK",
    "LINC02006",
    "KLF5",
    "WNT16",
    "NIBAN1",
    "LINC00355",
    "LINC01135",
    "MSR1",
    "MT2A",
    "LINC00299",
    "MX2",
    "NLGN4X",
    "LINC00886",
    "LINC00607",
    "NHSL2",
    "MYO1E",
    "NKAIN2",
    "NIPAL2",
    "MYO1F",
    "LINC01163",
    "NCMAP",
    "NHS",
    "MYRFL",
    "LINC02234",
    "LINC01182",
    "LINC01923",
    "LINC02246",
    "LINC02300",
    "LINC02306",
    "LINC02378",
    "LINC02664",
    "LINC02775",
    "LINC02798",
    "LINC02821",
    "LMNTD1",
    "LRRTM4",
    "LURAP1L-AS1",
    "LINC01934",
    "LY96",
    "MAP3K6",
    "LINC01877",
    "LINC01208",
    "LINC01876",
    "MCTP2",
    "LINC01842",
    "LINC01798",
    "LINC01579",
    "ME1",
    "MEGF11",
    "LINC01357",
    "MEOX2",
    "LINC01277",
    "MGAT4C",
    "LINC02055",
    "LINC01241",
    "MIR548XHG",
    "MIR222HG",
    "PTPN14",
    "OTP",
    "TAFA2",
    "TG",
    "TENT5A",
    "TENM2",
    "TEK",
    "TDO2",
    "TBX19",
    "TAPT1-AS1",
    "SYTL3",
    "THSD4",
    "SYT1",
    "SULF1",
    "SUCLG2-AS1",
    "STAT4",
    "STARD13",
    "STAC",
    "SPRY4-AS1",
    "TGM2",
    "TLR2",
    "SPATA48",
    "VEGFD",
    "WWTR1",
    "WIPF1",
    "WDR49",
    "VSTM2A-OT1",
    "VSTM2A",
    "VSIG4",
    "VLDLR-AS1",
    "UTY",
    "TMEM164",
    "UNC5C",
    "UNC13C",
    "TRPV4",
    "TRPM8",
    "TRPM3",
    "TRIM22",
    "TMEM63A",
    "SPINK5",
    "SPAG17",
    "PCA3",
    "POSTN",
    "RARRES1",
    "PTPRR",
    "LINC00158",
    "PTCHD4",
    "PTCHD1-AS",
    "PRSS48",
    "POU6F2",
    "PLIN2",
    "RNF6",
    "PLAC1",
    "PKD1L1",
    "PIP5K1B",
    "PGLYRP1",
    "PDE1C",
    "PCED1B",
    "PCDH11Y",
    "RASSF8",
    "RREB1",
    "SORCS1",
    "SLC18A1",
    "SOCS2-AS1",
    "SNTG1",
    "SMOC2",
    "SLIT2",
    "SLCO1B1",
    "SLC35G1",
    "SLC35E4",
    "SLC10A6",
    "RUNX1T1",
    "SIDT1",
    "SHOC1",
    "SAPCD2",
    "SAMD3",
    "SAA1",
    "RYR3",
    "RXRG",
    "LINC00278",
    "AC002074.1",
    "LGALS1",
    "AL117329.1",
    "ADAMTS3",
    "ADAMTS14",
    "ACOXL",
    "AC244472.1",
    "AC138409.3",
    "AC124947.1",
    "AC122697.1",
    "AC117464.1",
    "AC114689.3",
    "AC110023.1",
    "AC106845.1",
    "AC097518.2",
    "AC097462.3",
    "AC093535.1",
    "AC093523.1",
    "AC092958.2",
    "AC092957.1",
    "AGMO",
    "AL121904.2",
    "AC092131.1",
    "AL132633.1",
    "AP000446.1",
    "ALPK2",
    "ALDH1A2",
    "AL732509.1",
    "AL590608.1",
    "AL589935.1",
    "AL512452.1",
    "AL392086.3",
    "AL360178.1",
    "AL354696.2",
    "AL163636.1",
    "AL158195.1",
    "AL158058.1",
    "AL157911.1",
    "AL138824.1",
    "AL137139.2",
    "AL136038.5",
    "AC092819.3",
    "AC091078.1",
    "AP002495.1",
    "AC023095.1",
    "AC022325.2",
    "AC018616.1",
    "AC012404.1",
    "AC012063.1",
    "AC011246.1",
    "AC009646.2",
    "AC008080.4",
    "AC007681.1",
    "AC007389.1",
    "AC007364.1",
    "AC006994.2",
    "AC006387.1",
    "AC006206.2",
    "AC006041.2",
    "AC005162.3",
    "AC004943.2",
    "AC004879.1",
    "AC023051.1",
    "AC024145.1",
    "AC090578.1",
    "AC026202.2",
    "AC090403.1",
    "AC090337.2",
    "AC087627.1",
    "AC087473.1",
    "AC079950.1",
    "AC079763.1",
    "AC079465.1",
    "AC079298.3",
    "AC073529.1",
    "AC073050.1",
    "AC072062.1",
    "AC068305.2",
    "AC067956.1",
    "AC062022.2",
    "AC051619.6",
    "AC040174.1",
    "AC027097.2",
    "AP001025.1",
    "AP002813.1",
    "LCP2",
    "GPC3",
    "GNA14",
    "GLRA2",
    "GDNF-AS1",
    "GCNT2",
    "FYB1",
    "FXN",
    "FRG1-DT",
    "FRAS1",
    "FHIT",
    "FAR2",
    "FAP",
    "FAM189A1",
    "FAAH2",
    "ERI2",
    "EPSTI1",
    "EPHA3",
    "EPB41L4A",
    "GNGT1",
    "GREB1L",
    "EMILIN2",
    "GRIN2B",
    "LANCL3",
    "KREMEN1",
    "KCNMB4",
    "KCNE4",
    "ITK",
    "ITGAL",
    "INPP5D",
    "IL7",
    "IL12RB2",
    "IGSF10",
    "IAPP",
    "HS3ST3A1",
    "HRH1",
    "AC002429.2",
    "HMGB2",
    "HMGA2",
    "GRIP2",
    "ENOX2",
    "ELDR",
    "AP003066.1",
    "CFAP77",
    "CERNA2",
    "CDH18",
    "CDH13",
    "CD247",
    "CASC9",
    "C9orf153",
    "C9orf147",
    "BX284613.2",
    "BIRC3",
    "BEND6",
    "BCL2L14",
    "ATP8B4",
    "ASB18",
    "ARSJ",
    "ARRDC3-AS1",
    "ARHGAP11B",
    "APBB1IP",
    "CFAP47",
    "CFH",
    "EDN1",
    "CGNL1",
    "EBF2",
    "DOCK5",
    "DNAH3",
    "DIPK2A",
    "DANT2",
    "CPNE4",
    "COX8A",
    "COL4A6",
    "COL19A1",
    "COL12A1",
    "COBLL1",
    "CNTNAP3B",
    "CNDP1",
    "CNBD1",
    "CHRM3",
    "CHODL",
    "CHL1-AS2",
    "HNF4G"
  ],
  "programs": [
    {
      "program_name": "Mesenchymal Invasion & EMT",
      "description": "Coordinated upregulation of ECM-remodeling proteins (POSTN, TNC, COL19A1, ADAMTSs, SPOCK3), cell adhesion molecules (e.g., PCDH7, PCDH11X), and EMT regulators (HMGA2, RELN) highlight a mesenchymal gene program driving glioblastoma cell invasion. Matrix-crosslinking enzymes (TGM2) and pathways supporting cell migration and transition are collectively strengthened.",
      "atomic_biological_processes": [
        {
          "name": "ECM remodeling",
          "citation": [
            {
              "source_id": "",
              "notes": "POSTN regulates ECM, invasion, predicts glioma malignancy"
            },
            {
              "source_id": "",
              "notes": "Tenascin-C promotes glioblastoma invasion"
            }
          ],
          "genes": [
            "POSTN",
            "TNC",
            "COL19A1",
            "COL12A1",
            "ADAMTS18",
            "SPOCK3"
          ]
        },
        {
          "name": "Epithelial-mesenchymal transition",
          "citation": [
            {
              "source_id": "",
              "notes": "TGM2 triggers EMT signaling via matrix remodeling"
            },
            {
              "source_id": "",
              "notes": "HMGA2 sustains self-renewal and mesenchymal phenotype in GBM"
            }
          ],
          "genes": [
            "TGM2",
            "HMGA2",
            "RELN",
            "POSTN",
            "TNC"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "extracellular matrix",
          "citation": [
            {
              "source_id": "",
              "notes": "Glioma-induced ECM remodeling as a therapeutic target"
            }
          ],
          "genes": [
            "COL19A1",
            "COL12A1",
            "TNC",
            "POSTN",
            "SPOCK3",
            "ADAMTS18"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Enhanced invasion and migration",
        "Mesenchymal phenotype acquisition",
        "Resistance to therapy via EMT and ECM remodeling"
      ],
      "evidence_summary": "The presence and co-expression of ECM, EMT, and migration regulators highlight a robust mesenchymal invasive program as a hallmark of malignant glioblastoma phenotypes.",
      "significance_score": 0.95,
      "citations": [
        {
          "source_id": "",
          "notes": "POSTN as a functional/invasive driver"
        },
        {
          "source_id": "",
          "notes": "Role of tenascin-C in invasion"
        },
        {
          "source_id": "",
          "notes": "HMGA2 regulates mesenchymal phenotype"
        }
      ],
      "supporting_genes": [
        "POSTN",
        "TNC",
        "COL19A1",
        "COL12A1",
        "ADAMTS18",
        "SPOCK3",
        "TGM2",
        "HMGA2",
        "RELN"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "MMP2",
          "LOX",
          "FN1"
        ],
        "citations": [
          {
            "source_id": "",
            "notes": "Collagen, LOX, FN1 in GBM ECM and invasion"
          }
        ]
      }
    },
    {
      "program_name": "Immune Evasion & TAM Polarization",
      "description": "Genes such as MSR1, CD163, ALDH1A2, SULF1, TLR2, OLR1, and others are involved in immunosuppressive microenvironment creation, recruitment/activation of M2-like tumor-associated macrophages (TAMs), and resistance to immune-driven attack.",
      "atomic_biological_processes": [
        {
          "name": "Macrophage polarization and recruitment",
          "citation": [
            {
              "source_id": "",
              "notes": "MSR1 regulates M2-like TAMs in glioma"
            },
            {
              "source_id": "",
              "notes": "CD163 is a marker of TAMs in glioblastoma"
            }
          ],
          "genes": [
            "MSR1",
            "CD163",
            "ALDH1A2",
            "SULF1"
          ]
        },
        {
          "name": "Immunosuppressive signaling",
          "citation": [
            {
              "source_id": "",
              "notes": "OLR1 as driver of immunosuppression in tumor"
            },
            {
              "source_id": "",
              "notes": "SHIP1/INPP5D in myeloid-driven immunosuppression in GBM"
            }
          ],
          "genes": [
            "OLR1",
            "INPP5D"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "tumor-associated macrophage",
          "citation": [
            {
              "source_id": "",
              "notes": "CD163+ macrophages in glioblastoma tumor microenvironment"
            }
          ],
          "genes": [
            "CD163",
            "MSR1"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Immunosuppressive microenvironment",
        "Promotion of M2-like TAMs",
        "Therapy resistance via immune evasion"
      ],
      "evidence_summary": "The co-occurrence of TAM polarization and immunosuppressive signaling genes strongly supports the role of these pathways for immune escape in malignant glioblastoma.",
      "significance_score": 0.9,
      "citations": [
        {
          "source_id": "",
          "notes": "MSR1 drives M2-like TAMs"
        },
        {
          "source_id": "",
          "notes": "OLR1 and immunosuppression"
        }
      ],
      "supporting_genes": [
        "MSR1",
        "CD163",
        "ALDH1A2",
        "SULF1",
        "TLR2",
        "OLR1",
        "INPP5D"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "CSF1R",
          "ARG1",
          "STAT3"
        ],
        "citations": [
          {
            "source_id": "",
            "notes": "CSF1R, STAT3 as major TAM regulation signals"
          },
          {
            "source_id": "",
            "notes": "ARG1 in M2 TAMs"
          }
        ]
      }
    },
    {
      "program_name": "Calcium & Glutamate Signaling",
      "description": "Genes like RYR2, GRIN2B, TRPM8, TRPV4 and related ion channels coordinate calcium and glutamate-dependent signal transduction, which drive tumor cell excitability, migration, self-renewal, and therapy resistance in glioblastoma.",
      "atomic_biological_processes": [
        {
          "name": "Calcium signaling",
          "citation": [
            {
              "source_id": "",
              "notes": "SOC and Ca2+ signaling predominate in GSCs"
            },
            {
              "source_id": "",
              "notes": "NMDAR/GRIN2B drives radioresistance and migration"
            }
          ],
          "genes": [
            "RYR2",
            "TRPM8",
            "TRPV4",
            "TRPM3",
            "GRIN2B"
          ]
        },
        {
          "name": "Glutamate signaling",
          "citation": [
            {
              "source_id": "",
              "notes": "GBM releases glutamate, activates receptors driving excitability and growth"
            },
            {
              "source_id": "",
              "notes": "Glutamate and Ca2+ signaling promote invasion"
            }
          ],
          "genes": [
            "GRIN2B",
            "TRPM8"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "ion channel complex",
          "citation": [
            {
              "source_id": "",
              "notes": "NMDA receptor channel function in GBM"
            },
            {
              "source_id": "",
              "notes": "Diverse ion channels in GBM"
            }
          ],
          "genes": [
            "RYR2",
            "GRIN2B"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Enhanced excitability and migration",
        "Therapy resistance from altered Ca2+/glutamate signaling",
        "Promotion of stemness via NMDAR"
      ],
      "evidence_summary": "Calcium and glutamate channel genes are collectively upregulated in GBM, enabling diverse tumor behaviors including invasion, radioresistance, and stem cell self-renewal.",
      "significance_score": 0.8,
      "citations": [
        {
          "source_id": "",
          "notes": "Calcium channels drive GSC proliferation"
        },
        {
          "source_id": "",
          "notes": "NMDAR in GBM therapy resistance"
        }
      ],
      "supporting_genes": [
        "RYR2",
        "TRPM8",
        "TRPV4",
        "GRIN2B"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "CACNA1C",
          "SLC17A7"
        ],
        "citations": [
          {
            "source_id": "",
            "notes": "SLC17A7, CACNA1C as additional glutamate/Ca2+ pathway genes in GBM"
          }
        ]
      }
    },
    {
      "program_name": "Stemness & Plasticity Regulation",
      "description": "Upregulation of HMGA2, ALDH1A2, NLGN4X collectively indicate an epigenetic and cell surface adhesive program promoting glioblastoma stem cell self-renewal and plasticity.",
      "atomic_biological_processes": [
        {
          "name": "Stemness maintenance",
          "citation": [
            {
              "source_id": "",
              "notes": "HMGA2 sustains stemness and tumorigenicity in GBM"
            },
            {
              "source_id": "",
              "notes": "ALDH1A2 in GBM stem-like cells and microenvironment"
            }
          ],
          "genes": [
            "HMGA2",
            "ALDH1A2"
          ]
        },
        {
          "name": "Synaptic adhesion",
          "citation": [
            {
              "source_id": "",
              "notes": "NLGN4X regulates growth cone and synaptic organization"
            }
          ],
          "genes": [
            "NLGN4X"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "glioma stem cell niche",
          "citation": [
            {
              "source_id": "",
              "notes": "GBM stem cell hierarchy and niche in resistance"
            }
          ],
          "genes": [
            "HMGA2",
            "ALDH1A2"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Increased self-renewal/plasticity",
        "Promotion of resistant, multipotent tumor cells"
      ],
      "evidence_summary": "Stemness regulators HMGA2/ALDH1A2 and synaptic cues like NLGN4X are upregulated, driving plasticity and treatment resistance in GBM.",
      "significance_score": 0.75,
      "citations": [
        {
          "source_id": "",
          "notes": "HMGA2 as GBM stemness regulator"
        },
        {
          "source_id": "",
          "notes": "ALDH1A2 expression in GSCs"
        }
      ],
      "supporting_genes": [
        "HMGA2",
        "ALDH1A2",
        "NLGN4X"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "SOX2",
          "PROM1"
        ],
        "citations": [
          {
            "source_id": "",
            "notes": "SOX2 as canonical GSC stemness factor"
          }
        ]
      }
    }
  ],
  "method": {
    "clustering_basis": [
      "pathway enrichment",
      "co-citation",
      "protein-protein interaction",
      "co-expression analysis",
      "literature correlation"
    ],
    "notes": "Highly cited experimental and review literature was prioritized for functional term assignment; pathway databases corroborated major gene programs and connections. Cross-validation against glioblastoma stem cell, invasion, immune-TAM, and synaptic datasets."
  },
  "version": "2025-11-17"
}